LOGOLOGOLOGOLOGO
  • About us
    • What we do
    • Who we are
      • Governance
      • Staff
      • Vacancies
  • Members
    • EuropaBio Members
    • About Membership
  • How we work
    • Healthcare Biotechnology Council
      • Patient BioForum
      • Study – Impact of the EU’s General Pharmaceutical Legislation
    • Industrial Biotechnology Council
      • EFIB
      • Microorganisms
    • National Associations Council
    • SME Platform
    • Biomanufacturing Platform
      • Biotechnology in our Lives
  • Activities
    • 25 Years of Innovation
    • The EU Biotech Act
    • European Biotech Week
    • EU Projects
      • PRIMED Project
      • APROVALS Project
  • News & Events
    • News
    • Events
  • Library
Become a member
✕

Dr Anne-Gaëlle Collot new Industrial Biotechnology Director at EuropaBio

09/05/2023
NEWS RELEASE

Brussels, 9 May 2023 – EuropaBio is pleased to announce that Dr Anne-Gaëlle Collot joins EuropaBio’s Industrial Biotechnology team as Industrial Biotechnology Director.

Anne-Gaëlle holds a PhD in Chemical Engineering from Imperial College London. Prior to joining EuropaBio, she worked for 20 years on sustainability and environmental policies in several trade associations representing the chemicals and plastics industries, including the Chemicals Industry Association (CIA) and most recently, Plastics Europe both in Brussels and in the UK. Anne-Gaëlle is a French national with two children, and enjoys practicing Pilates and growing house plants.

Speaking about her appointment, Anne-Gaëlle said: “I am very pleased to have been appointed by the EuropaBio team. I am looking forward to building on my experience in the chemicals, plastics industries alongside my research background to enable a strong and competitive industrial biotechnology in Europe to support the green transition."

Claire Skentelbery, Director General of EuropaBio commented: “We are delighted to welcome Dr Anne-Gaelle Collot to the EuropaBio team. With her track record in sustainability and public affairs, we look forward to a strong future for industrial biotechnology across sectors in Europe's industrial and green transition."

Anne-Gaëlle will take on the new role with immediate effect.

Share
Alexandra Simionca
Alexandra Simionca

Related posts

22/05/2025

Adisseo joins EuropaBio: Feeding Animals Sustainably Around the World


Read more
21/05/2025

Ensuring Biotech Integration in the Single Market


Read more
10/04/2025

EU biotechnology competitiveness for the future; high level dialogue with EVP Séjourné


Read more

Important links

  • Adisseo joins EuropaBio: Feeding Animals Sustainably Around the World
  • Ensuring Biotech Integration in the Single Market

Categories in our Newsroom

EBIO-white

EuropaBio represents corporate and associate members across sectors, plus national and regional biotechnology associations which, in turn, represent over 5000 biotech companies, 4600 out of them are SMEs.

Contact us

Extra links

Members
Staff
Privacy policy
Legal & cookies
Events
Newsroom

Become a member

Media pack

© 2025 Europabio. All Rights Reserved. Designed by EYAS
Become a member

Algal Omega 3

Algal Omega-3 is an innovative feed product for aquaculture. It reduces the impact on climate change by 30-40% compared to fish oil and saves 60 tons of wild fish for every ton of Algal Omega-3 used.

Cheese

Cheese is a vegetarian product thanks to biotechnology. Biotechnology is also essential to produce lactose- or cholesterol-free cheese, as well as alternative proteins.

Clothes

Clothes made from alternative fibres produced by microorganisms can be 8x stronger than steel, 100% recyclable, biodegradable and replace fossil-fuel based or resource-intensive textiles.

Vitamin B2

The biomanufacturing of Vitamin B2 led to the reduction of 75% of fossil raw materials and 50% operating costs, compared to the chemical process. Vitamin B2 is used in the food, feed or healthcare sectors.

Detergents

Enzymes and biosurfactancts are alternative ingredients that improve the performance of detergents, while leading to water and energy savings and reductions in CO2 emissions and water toxicity.

Insulin

Insulin is one of the most widely known biopharmaceutical. Biotechnology revolutionised its manufacturing process and led to the development of new types of insulin through r-DNA technology.